Arcturus Therapeutics Holdings Inc (ARCT)
16.91
-0.16
(-0.94%)
USD |
NASDAQ |
Nov 22, 16:00
16.94
+0.03
(+0.18%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Cash from Investing (Quarterly): -0.08M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -0.08M |
| June 30, 2024 | -0.328M |
| March 31, 2024 | -0.24M |
| December 31, 2023 | -0.875M |
| September 30, 2023 | -0.981M |
| June 30, 2023 | -0.354M |
| March 31, 2023 | -0.691M |
| December 31, 2022 | -3.807M |
| September 30, 2022 | -2.186M |
| June 30, 2022 | 0.378M |
| March 31, 2022 | -2.111M |
| December 31, 2021 | -1.118M |
| September 30, 2021 | -1.766M |
| June 30, 2021 | -0.404M |
| March 31, 2021 | -0.118M |
| December 31, 2020 | -0.697M |
| September 30, 2020 | -0.434M |
| June 30, 2020 | -0.469M |
| March 31, 2020 | -0.142M |
| December 31, 2019 | -0.315M |
| September 30, 2019 | -0.159M |
| June 30, 2019 | -0.266M |
| March 31, 2019 | -0.078M |
| December 31, 2018 | 2.269M |
| Date | Value |
|---|---|
| September 30, 2018 | 7.823M |
| June 30, 2018 | 0.817M |
| March 31, 2018 | 11.22M |
| December 31, 2017 | 10.46M |
| September 30, 2017 | -0.084M |
| June 30, 2017 | -7.35M |
| March 31, 2017 | 7.334M |
| December 31, 2016 | -3.617M |
| September 30, 2016 | -4.043M |
| June 30, 2016 | 5.712M |
| March 31, 2016 | 1.26M |
| December 31, 2015 | 6.033M |
| September 30, 2015 | 6.783M |
| June 30, 2015 | 4.976M |
| March 31, 2015 | -18.01M |
| December 31, 2014 | 7.203M |
| September 30, 2014 | 5.291M |
| June 30, 2014 | 1.988M |
| March 31, 2014 | -6.075M |
| December 31, 2013 | -12.98M |
| September 30, 2013 | -11.06M |
| June 30, 2013 | -4.003M |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-3.807M
Minimum
Dec 2022
0.378M
Maximum
Jun 2022
-0.8369M
Average
-0.4515M
Median
Cash from Investing (Quarterly) Benchmarks
| Bioventus Inc | -0.064M |
| Fulcrum Therapeutics Inc | 4.35M |
| Pfizer Inc | -2.057B |
| AIM ImmunoTech Inc | 0.334M |
| Protalix BioTherapeutics Inc | 20.33M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.76M |
| Cash from Financing (Quarterly) | 0.693M |
| Free Cash Flow | -61.62M |
| Free Cash Flow Per Share (Quarterly) | -0.8811 |
| Free Cash Flow to Equity (Quarterly) | -23.84M |
| Free Cash Flow to Firm (Quarterly) | -23.84M |
| Free Cash Flow Yield | -13.53% |